Corient Private Wealth
BIOA

Corient Private Wealth’s BioAge Labs BIOA Stock Holding History

Corient Private Wealth’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$987K Buy
40,258
+17,476
+77% +$316K ﹤0.01% 1832
2026
Q1 		$389K Buy
+22,782
New +$439K ﹤0.01% 2169

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Corient Private Wealth's BIOA Position: Q2 2026 in Review

Corient Private Wealth increased its BioAge Labs (BIOA) stake by 77% in Q2 2026, buying an estimated $316K and bringing the position to 40,258 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

Corient Private Wealth first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Corient Private Wealth held 40,258 shares of BioAge Labs worth $987K as of Q2 2026.
  • Corient Private Wealth bought 17,476 BioAge Labs shares in Q2 2026, an estimated $316K.
  • BioAge Labs made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1832 holding.
  • Corient Private Wealth first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.